Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse events
Volume: 54, Issue: 5, Pages: 294 - 299
Published: Apr 15, 2020
Abstract
Background. Liraglutide, a glucagon-like peptide-1 agonist, is used for treatment of type 2 diabetes and has beneficial cardiovascular properties. However, treatment increases heart rate (HR) and possibly the risk of cardiovascular events in chronic heart failure (CHF) patients. We investigated potential associations between HR changes and clinical, laboratory and echocardiographic parameters and clinical events in liraglutide treated CHF...
Paper Details
Title
Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse events
Published Date
Apr 15, 2020
Volume
54
Issue
5
Pages
294 - 299
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History